Immune Response Following Seasonal Influenza Vaccination

Summary

This is an open-label, single administration dose study in adult healthy male and female subjects. After qualifying for the study, subjects will receive a single intramuscular injection of the FDA approved 2016-2017 quadrivalent influenza vaccine.

Timeline

Start

2017-05-08

Primary completion

2017-11-21

Completion

2018-06-15

Drugs

Indications